Karyopharm Therapeutics (KPTI) Earnings Date & Reports

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

KPTI is expected to report earnings to rise 5.65% to -130 cents per share on July 30

Karyopharm Therapeutics KPTI Stock Earnings Reports

Q2'26

Est.

$-1.31

Q1'26

Missed

by $1.15

Q4'25

Missed

by $5.48

Q3'25

Missed

by $3.60

Q2'25

Missed

by $4.22

The last earnings report on May 14 showed earnings per share of -124 cents, missing the estimate of -9 cents. With 311.01K shares outstanding, the current market capitalization sits at 228.67M.

View a ticker or compare two or three

Compare

KPTI

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for KPTI